SCHEMBL329557

SCHEMBL329557

Oc1cccc2c1[nH]c1ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.62
KIF11 P52732 4/20 0.59
IMPDH2 P12268 1/20 0.59
IMPDH1 P20839 1/20 0.59
ALDH1A1 P00352 2/20 0.54
HSD17B10 Q99714 2/20 0.54
GPR3 P46089 1/20 0.54
GABRP O00591 2/20 0.52
GABRD O14764 2/20 0.52
GABRA1 P14867 2/20 0.52
GABRB1 P18505 2/20 0.52
GABRG2 P18507 2/20 0.52
GABRB3 P28472 2/20 0.52
GABRA5 P31644 2/20 0.52
GABRA3 P34903 2/20 0.52
GABRA2 P47869 2/20 0.52
GABRB2 P47870 2/20 0.52
GABRA4 P48169 2/20 0.52
GABRE P78334 2/20 0.52
GABRA6 Q16445 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28467939 0.98 AR (0.61) ARKIF11IMPDH2IMPDH1ALDH1A1
SCHEMBL28463756 0.98 AR (0.61) ARKIF11IMPDH2IMPDH1ALDH1A1
SCHEMBL10868611 0.98 AR (0.61) ARKIF11IMPDH2IMPDH1ALDH1A1
Biphenyl SCHEMBL3486918 0.94 AR (0.57) ARKIF11IMPDH2IMPDH1ALDH1A1
Acetic Acid SCHEMBL27471236 0.89 PARP14 (0.56) ARKIF11IMPDH2IMPDH1PARP14
SCHEMBL28911952 0.88 AR (0.51) ARKIF11IMPDH2IMPDH1ALDH1A1
SCHEMBL30600352 0.84 PARP14 (0.59) KIF11IMPDH2IMPDH1PARP14CA1
SCHEMBL4010925 0.84 TDP1 (0.64) ARIMPDH2IMPDH1ALDH1A1CHEK1
SCHEMBL15455181 0.84 PARP14 (0.59) KIF11IMPDH2IMPDH1PARP14CA1
SCHEMBL11814599 0.84 AR (0.57) ARIMPDH2IMPDH1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 516 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504563-A Continuous flow production process of hydroxycarbazole 华东理工大学 2025-02-25 CN claimed
US-12156415-B2 Method of patterning light emitting layer, and method of manufacturing light-emitting diode device BOE TECHNOLOGY GROUP CO., LTD. (CN) 2024-11-26 US claimed
CN-113692638-B Quantum dot light-emitting device and preparation method thereof, and preparation method of quantum dot display panel 京东方科技集团股份有限公司 2024-09-06 CN claimed
CN-114058306-B Underfill adhesive, and preparation method and application thereof 韦尔通科技股份有限公司 2023-07-21 CN claimed
CN-116041248-B Carbazole derivative with anticancer activity and preparation method and application thereof 成都摩诃大龙医药科技有限公司 2023-06-06 CN claimed
CN-116041248-A Carbazole derivative with anticancer activity and preparation method and application thereof 成都摩诃大龙医药科技有限公司 2023-05-02 CN claimed
US-20230021056-A1 METHOD OF PATTERNING LIGHT EMITTING LAYER, AND METHOD OF MANUFACTURING LIGHT-EMITTING DIODE DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2023-01-19 US claimed
CN-111286020-B Preparation method of polyether polyol with fluorescent characteristic 山东蓝星东大有限公司 2022-12-27 CN claimed
CN-114058306-A Underfill adhesive and preparation method and application thereof 韦尔通(厦门)科技股份有限公司 2022-02-18 CN claimed
WO-2022001531-A1 METHOD FOR PATTERNING LIGHT EMITTING LAYER, AND METHOD FOR MANUFACTURING LIGHT EMITTING DIODE DEVICE 京东方科技集团股份有限公司 2022-01-06 WO claimed
US-20070197797-A1 Compounds and methods for carbazole synthesis ROCHE COLORADO CORPORATION 2007-08-23 US claimed
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO claimed
CN-1751108-A Thermal liquids providing glass corrosion protection especially for solar systems BASF AG (DE) 2006-03-22 CN claimed
CN-1173973-C Benzocarbazole and indenoindole derived estrogenic agents 2004-11-03 CN claimed
CN-1354740-A Pharmaceutical compounds NICOX SA (FR) 2002-06-19 CN claimed
WO-1998038986-A2 USE OF CARVEDILOL OR DERIVATIVES THEREOF FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF VIRAL INFECTIONS ROCHE DIAGNOSTICS GMBH (DE) 1998-09-11 WO claimed
WO-1998038985-A2 USE OF CARVEDILOL FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTIVE AND THERAPEUTIC TREATMENT OF INFLAMMATORY DISEASES ROCHE DIAGNOSTICS GMBH (DE) 1998-09-11 WO claimed
EP-0124086-B1 PROCESS FOR THE PRODUCTION OF RESIST PRINTS HOECHST AKTIENGESELLSCHAFT (DE) 1986-12-17 EP claimed
EP-0102833-A1 Carboxylation of metal aryloxides Euroceltique S.A. (LU) 1984-03-14 EP claimed
US-4010151-A Water insoluble mono azo and disazo dyes containing cinnamonitrile group PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1977-03-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197797-A1 Compounds and methods for carbazole synthesis CNR2, CNR1, CYP2J2 AR 563/4885KIF11 3781/4885IMPDH2 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.